vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $134.9M, roughly 1.5× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 2.7%, a 79.9% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 27.1%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 25.8%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
CTRE vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $208.9M |
| Net Profit | $111.3M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | — | 1.1% |
| Net Margin | 82.5% | 2.7% |
| Revenue YoY | 55.1% | 27.1% |
| Net Profit YoY | 113.5% | 518.5% |
| EPS (diluted) | $0.52 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $134.9M | $208.9M | ||
| Q3 25 | $132.4M | $192.9M | ||
| Q2 25 | $112.5M | $186.7M | ||
| Q1 25 | $96.6M | $158.7M | ||
| Q4 24 | $86.9M | $164.3M | ||
| Q3 24 | $77.4M | $147.5M | ||
| Q2 24 | $68.9M | $148.0M | ||
| Q1 24 | $63.1M | $131.9M |
| Q4 25 | $111.3M | $5.6M | ||
| Q3 25 | $74.9M | $-5.2M | ||
| Q2 25 | $68.5M | $-14.2M | ||
| Q1 25 | $65.8M | $-30.7M | ||
| Q4 24 | $52.1M | $-1.3M | ||
| Q3 24 | $33.4M | $-46.2M | ||
| Q2 24 | $10.8M | $-20.1M | ||
| Q1 24 | $28.7M | $-45.7M |
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% | ||
| Q1 24 | — | 66.3% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | 58.1% | -4.4% | ||
| Q2 25 | 61.3% | -10.0% | ||
| Q1 25 | — | -20.5% | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | 43.0% | -34.1% | ||
| Q2 24 | 15.1% | -15.5% | ||
| Q1 24 | — | -28.9% |
| Q4 25 | 82.5% | 2.7% | ||
| Q3 25 | 56.6% | -2.7% | ||
| Q2 25 | 60.9% | -7.6% | ||
| Q1 25 | 68.1% | -19.3% | ||
| Q4 24 | 60.0% | -0.8% | ||
| Q3 24 | 43.2% | -31.3% | ||
| Q2 24 | 15.6% | -13.6% | ||
| Q1 24 | 45.6% | -34.6% |
| Q4 25 | $0.52 | $0.18 | ||
| Q3 25 | $0.35 | $-0.16 | ||
| Q2 25 | $0.35 | $-0.44 | ||
| Q1 25 | $0.35 | $-0.97 | ||
| Q4 24 | $0.30 | $-0.03 | ||
| Q3 24 | $0.21 | $-1.48 | ||
| Q2 24 | $0.07 | $-0.65 | ||
| Q1 24 | $0.22 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $583.8M |
| Total DebtLower is stronger | $894.2M | — |
| Stockholders' EquityBook value | $4.0B | $152.7M |
| Total Assets | $5.1B | $1.0B |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.0M | $583.8M | ||
| Q3 25 | $712.5M | $565.2M | ||
| Q2 25 | $306.1M | $545.5M | ||
| Q1 25 | $26.5M | $520.6M | ||
| Q4 24 | $213.8M | $535.6M | ||
| Q3 24 | $377.1M | $522.0M | ||
| Q2 24 | $495.1M | $561.5M | ||
| Q1 24 | $451.2M | $569.1M |
| Q4 25 | $894.2M | — | ||
| Q3 25 | $893.8M | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $822.1M | — | ||
| Q4 24 | $396.9M | — | ||
| Q3 24 | $396.7M | — | ||
| Q2 24 | $671.1M | — | ||
| Q1 24 | $595.9M | — |
| Q4 25 | $4.0B | $152.7M | ||
| Q3 25 | $4.0B | $121.9M | ||
| Q2 25 | $3.3B | $103.7M | ||
| Q1 25 | $2.9B | $86.7M | ||
| Q4 24 | $2.9B | $90.9M | ||
| Q3 24 | $2.4B | $71.8M | ||
| Q2 24 | $1.9B | $99.2M | ||
| Q1 24 | $1.7B | $90.3M |
| Q4 25 | $5.1B | $1.0B | ||
| Q3 25 | $5.1B | $995.2M | ||
| Q2 25 | $4.7B | $964.0M | ||
| Q1 25 | $3.9B | $926.1M | ||
| Q4 24 | $3.4B | $931.4M | ||
| Q3 24 | $2.9B | $909.7M | ||
| Q2 24 | $2.7B | $919.2M | ||
| Q1 24 | $2.3B | $909.8M |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 3.54× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.0M | $26.2M | ||
| Q3 25 | $100.9M | $34.9M | ||
| Q2 25 | $100.8M | $27.7M | ||
| Q1 25 | $71.4M | $-7.9M | ||
| Q4 24 | $244.3M | $19.2M | ||
| Q3 24 | $67.2M | $24.3M | ||
| Q2 24 | $53.0M | $11.8M | ||
| Q1 24 | $48.8M | $-52.0M |
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $-61.8M |
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -46.8% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | 3.54× | 4.70× | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 4.68× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRE
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
